Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anixa Biosciences

3.22
-0.1500-4.45%
Post-market: 3.250.0301+0.93%17:22 EDT
Volume:85.60K
Turnover:280.42K
Market Cap:103.72M
PE:-8.53
High:3.38
Open:3.38
Low:3.21
Close:3.37
Loading ...

Anixa Biosciences Receives Buy Rating Amidst Strong Patent Portfolio and Promising Vaccine Trials

TIPRANKS
·
24 Jul

Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine Ip Protection Into 2040S

THOMSON REUTERS
·
24 Jul

Anixa Biosciences Secures New U.S. Patent, Strengthening IP for Innovative Breast Cancer Vaccine Platform

Reuters
·
24 Jul

Director Makes Strategic Move with Anixa Biosciences Stock Purchase

TIPRANKS
·
22 Jul

Director Arnold M. Baskies Reports Acquisition of Common Shares in Anixa Biosciences Inc

Reuters
·
21 Jul

Director Lewis H. Titterton Jr. Reports Acquisition of Anixa Biosciences Common Shares

Reuters
·
15 Jul

CEO’s Bold Move: Major Stock Purchase in Anixa Biosciences!

TIPRANKS
·
15 Jul

Amit Kumar, CEO, Reports Acquisition of Common Shares in Anixa Biosciences Inc

Reuters
·
14 Jul

Anixa announces issuance of additional USPTO for ovarian cancer vaccine tech

TIPRANKS
·
09 Jul

Anixa Biosciences Initiates Fourth Cohort Dosing in Groundbreaking Ovarian Cancer CAR-T Clinical Trial

Reuters
·
23 Jun

Anixa Biosciences to Host Investor Webcast Featuring CEO Presentation and Q&A Session

Reuters
·
20 Jun

Anixa Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
10 Jun

Anixa Biosciences Announces Presentation of Ovarian Cancer CAR-T Clinical Trial Results at ESMO Gynaecological Cancers Congress 2025

Reuters
·
09 Jun

CEO Amit Kumar Reports Acquisition of Common Shares in Anixa Biosciences Inc

Reuters
·
05 Jun

Promising Developments at Anixa Biosciences: Buy Rating Reiterated with $7 Price Target

TIPRANKS
·
03 Jun

Anixa Biosciences CEO Highlights Breakthrough Breast Cancer Vaccine on NewsNation Interview

Reuters
·
03 Jun

Anixa Biosciences Completes Enrollment in Phase 1 Trial of Breast Cancer Vaccine Funded by U.S. Department of Defense

Reuters
·
02 Jun

Anixa Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
29 May

Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th

PR Newswire
·
30 Apr

BRIEF-Anixa Biosciences- Receives Notice Of Allowance For Car-T Technology Patent

Reuters
·
14 Apr